Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89
In Brief: Hammer Okay, Panel’s Pittsburgh Meeting Rescheduled For Oc 23; Campbell Leaves AICR
DeVita: No Decision Yet On FCRF Award
DCE Board Recompetition Concepts
ACS Research Budget Over $82 Million
Pesticides Increase Leukemia Risk, USA Investigations Report
Cancer Atlast Offers New Research Leads
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









